Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-01-2023 | NSCLC | Case report

Nivolumab

Various toxicities: 5 case reports

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Sebastian M, et al. Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung). Journal of Immunotherapy 45: 89-99, No. 2, Feb 2022. Available from: URL: https://www.lww.com/store/products?1053-8550 Sebastian M, et al. Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung). Journal of Immunotherapy 45: 89-99, No. 2, Feb 2022. Available from: URL: https://​www.​lww.​com/​store/​products?​1053-8550
Metadata
Title
Nivolumab
Various toxicities: 5 case reports
Publication date
01-01-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-31164-2

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue